Products
| Product Name | CAS No. | Specification | Application | Registration |
| N-Acetyl-Calicheamicin | 108212-76-6 | 98+% | Cancer Targeted Therapy | |
| Nemorubicin | 108852-90-0 | 98+% | antitumor activity | |
| Nifursol | 16915-70-1 | 98+% | veterinary antibiotic | |
| Nirmatrelvir | 2628280-40-8 | 99+% | SARS-CoV inhibitor | COVID-19 inhibitor | |
| Nocodazole | 31430-18-9 | 98+% | ||
| N-Acetyl-β-Asp-Glu (β-NAAG) | 4910-46-7 | 98+% | ||
| Nifedipine | 21829-25-4 | 99+% | ||
| Naringin Dihydrochalcone | 18916-17-1 | 99+% | ||
| Neohesperidin Dihydrochalcone (NHDC) | 20702-77-6 | 99+% | ||
| Nicotinamide Riboside Chloride | 23111-00-4 | 99+% | ||
| Necrosulfonamide | 1360614-48-7 | 98+% | ||
| Nomilin | 1063-77-0 | 98+% | ||
| Nintedanib Ethanesulfonate Salt | 656247-18-6 | 99+% | VEGFR inhibitor | FGFR inhibitor | PDGFR inhibitor | Src inhibitor | |
| Nelarabine (506U78) | 121032-29-9 | 99+% | Anti-cancer | DNA/RNA Synthesis inhibitor | |
| Nintedanib (BIBF 1120) | 656247-17-5 | 98+% | VEGFR inhibitor | FGFR inhibitor| PDGFR inhibitor | Src inhibitor |
Products
Custom Synthesis-High Value-Added Advanced Pharmaceutical Intermediates
E-Mail: sales (at)Chemleader.com.cn
E-Mail: sales (at)Chemleader.com.cn